Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Weimar C et al. – The authors conclude that aspirin, clopidogrel or dipyridamol–aspirin are the cornerstone therapies in patients with noncardioembolic stroke. More potent antiplatelet drugs or the combination of aspirin and clopidogrel prevent more ischemic events but also lead to more bleeding complications. For secondary stroke prevention in patients with atrial fibrillation, oral anticoagulation is more effective than aspirin or the combination of aspirin and clopidogrel.

Today in Vascular Medicine...keeping you current

Oxidative Stress and Platelet Activation: Markers of Myocardial Infarction in Type 2 Diabetes Mellitus
Angiology, 11/20/09

Mechanisms of Tissue Injury in Renal Artery Stenosis: Ischemia and Beyond
Progress in Cardiovascular Diseases , 11/20/09

Feasibility and Safety of Transcatheter Intervention for Complex Patent Ductus Arteriosus
Angiology, 11/20/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address